Adalimumab 83012-0012
Product NDC
83012-0012- Manufacturer
- Boehringer Ingelheim Fremont, Inc.
- Dosage Form
- Liquid
- Product Type
- Drug For Further Processing
- Marketing Start
- July 11, 2018
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Adalimumab-Adbm | 20 mg/.4mL |
Packaging Options(1)
1 mL in 1 SYRINGE (83012-012-10)